Jade Biosciences, Inc.

Stock Chart, Company Information, and Scan Results

$21.84(as of Aug 25, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Jade Biosciences, Inc. Company Information, Fundamentals, and Technical Indicators

Stock Price$21.84
Ticker SymbolJBIO
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees55
CountyUSA
Market Cap$1,357.2M
EBIDTA-164.7M
10-Day Moving Average22.70
P/E Ratio0.00
20-Day Moving Average21.83
Forward P/E Ratio0.00
50-Day Moving Average21.03
Earnings per Share-1.08
200-Day Moving Average17.58
Profit Margin0.00%
RSI50.88
Shares Outstanding63.6M
ATR1.50
52-Week High28.00
Volume603,005
52-Week Low6.91
Most Recent Support Level20.40
Book Value0.0M
Most Recent Resistance Level24.33
P/B Ratio0.00
Upper Keltner25.21
P/S Ratio0.00
Lower Keltner18.45
Debt-to-Equity Ratio0.00
Next Earnings DateUnknown
Cash Surplus0.0M
Next Ex-Dividend DateUnknown

Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts.

Jade Biosciences, Inc. In Our Stock Scanner

As of Aug 25, 2026
example chart graphic
Scan Name: Falling WedgeScan Type: Chart Pattern Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.